Bank Of New York Mellon Corp G1 Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$2.57 - $8.16 $49,585 - $157,439	19,294 New	19,294 $51.7 Million
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $100,135 - $260,469	19,294 New	19,294 $104,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $20,018 - $65,785	3,872 Added 24.78%	19,497 $243,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $463,165 - $975,628	-114,645 Reduced 88.01%	15,625 $77,000
Q1 2022 May 11, 2022	BUY	$7.6 - $11.02 $2,287 - $3,317	301 Added 0.23%	130,270 $990,000
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $47,945 - $76,306	4,719 Added 3.77%	129,969 $1.33 Million
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $137,179 - $234,227	10,424 Added 9.08%	125,250 $1.68 Million
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $311,965 - $419,567	-15,941 Reduced 12.19%	114,826 $2.52 Million
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $13,501 - $25,029	-768 Reduced 0.58%	130,767 $3.15 Million
Q4 2020 Feb 09, 2021	SELL	$10.99 - $20.4 $95,393 - $177,072	-8,680 Reduced 6.19%	131,535 $2.37 Million
Q3 2020 Nov 12, 2020	SELL	$11.55 - $23.75 $9,309 - $19,142	-806 Reduced 0.57%	140,215 $1.62 Million
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $69,813 - $177,779	7,295 Added 5.46%	141,021 $3.42 Million
Q1 2020 May 06, 2020	SELL	$9.07 - $26.32 $5,215 - $15,134	-575 Reduced 0.43%	133,726 $1.47 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $41,572 - $62,744	2,024 Added 1.53%	134,301 $3.55 Million
Q3 2019 Nov 07, 2019	SELL	$22.78 - $40.58 $65,310 - $116,342	-2,867 Reduced 2.12%	132,277 $3.01 Million
Q2 2019 Aug 12, 2019	SELL	$16.03 - $31.1 $15.7 Million - $30.5 Million	-979,181 Reduced 87.87%	135,144 $4.14 Million
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $394,776 - $588,051	27,415 Added 2.52%	1,114,325 $18.5 Million
Q4 2018 Feb 11, 2019	SELL	$16.51 - $51.33 $2.95 Million - $9.19 Million	-178,972 Reduced 14.14%	1,086,910 $20.8 Million
Q3 2018 Nov 09, 2018	BUY	$43.15 - $67.97 $124,746 - $196,501	2,891 Added 0.23%	1,265,882 $0
Q2 2018 Aug 06, 2018	BUY	$35.06 - $51.17 $41.5 Million - $60.6 Million	1,183,940 Added 1497.69%	1,262,991 $54.9 Million
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $946,975 - $2.08 Million	49,710 Added 169.42%	79,051 $2.93 Million
Q4 2017 Feb 09, 2018	BUY	$19.01 - $26.2 $557,772 - $768,734	29,341	29,341 $582,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account